Healthcare Services

Breath Biopsy Testing Market Growth Prospects 2026–2030 with Innovation Trends and Competitive Landscape

March 30, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

How Large Is The Breath Biopsy Testing Market Projected To Become By 2030 Based On Its 2026 Valuation?

The breath biopsy testing market size has experienced substantial growth in recent years. It is anticipated to expand from $3.43 billion in 2025 to $3.69 billion in 2026, achieving a compound annual growth rate (CAGR) of 7.7%. The historical growth in this sector is largely due to factors such as an increasing need for non-invasive diagnostics, the broadening of clinical research focused on breath biomarkers, significant advancements in sensor and spectroscopy technologies, the expansion of diagnostic laboratory services, and a growing patient preference for painless testing methods.

The breath biopsy testing market is projected to experience robust expansion in the coming years, with its size anticipated to reach $4.9 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 7.3%. This expected growth during the forecast period is largely driven by factors such as the increasing adoption of breath-based diagnostics in routine screening, a rise in investments towards AI-enabled diagnostic platforms, the expansion of personalized medicine applications, the growing utilization of portable diagnostic devices, and stronger regulatory support for non-invasive testing. Prominent trends throughout this period will encompass the increasing embrace of non-invasive diagnostic techniques, a rising application of VOC-based disease detection, the deepening integration of AI-driven breath analysis, the broader deployment of portable breath sampling devices, and an intensified focus on early disease screening.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=19351&type=smp

What Primary Drivers Are Shaping The Development Of The Breath Biopsy Testing Market?

The growing incidence of respiratory ailments is poised to fuel the expansion of the breath biopsy testing market. These are medical conditions affecting the lungs and airways, thereby impeding efficient respiration. Factors contributing to their widespread occurrence include escalating environmental pollution, elevated smoking rates, and the increasing presence of chronic illnesses such as asthma and chronic obstructive pulmonary disease (COPD). Breath biopsy testing is crucial for respiratory diseases as it provides a non-invasive, rapid, and potentially more accurate approach for identifying biomarkers linked to these conditions, thereby enhancing early detection and management. For instance, as reported in May 2025 by the Centers for Disease Control and Prevention (CDC), a US-based government public health agency, chronic obstructive pulmonary disease (COPD) stood as the fifth leading cause of mortality in the United States in 2023, resulting in 141,733 deaths. Furthermore, during the same year, the age-adjusted prevalence of diagnosed COPD among adults reached 3.8%. Consequently, the increasing occurrence of respiratory diseases is expected to stimulate the growth of the breath biopsy testing market.

What Segment Groups Are Identified Within The Breath Biopsy Testing Market?

The breath biopsy testing market covered in this report is segmented –

1) By Type: Volatile Organic Compound Analyzers, Breath Biopsy Kits, Breath Sampler, Other Types

2) By Technology: Fuel Cell Technology, Semiconductor Sensor, Infrared (IR) Spectroscopy, Other Technologies

3) By Application: Hospitals, Clinics, Diagnostics Laboratories, Other Applications

Subsegments:

1) By Volatile Organic Compound (VOC) Analyzers: Gas Chromatography-Mass Spectrometry (GC-MS) Analyzers, Photoionization Detectors (PID), Electronic Nose Devices

2) By Breath Biopsy Kits: Sample Collection Kits, Analysis Kits For Specific Biomarkers, Packaging And Transport Kits

3) By Breath Sampler: Breath Collection Bags, Breath Sampling Tubes, Portable Breath Sampling Devices

4) By Other Types: Breath Testing Devices For Specific Conditions, Software For Data Analysis, Calibration Devices For Breath Analyzers

Which Trends Are Influencing The Breath Biopsy Testing Market?

Leading companies in the breath biopsy testing market are concentrating on developing innovative products, such as breath analyzers, for detecting asthma. Breath analyzers are diagnostic tools designed to identify and measure specific compounds in a person’s breath to pinpoint medical conditions or gauge health status. For example, in May 2023, GenWorks, an India-based healthcare solutions provider, introduced the FenomPro breath analyzer. The FenomPro breath analyzer stands out with its rapid FeNO testing capability, yielding results in just 28 seconds. Created for simple operation in clinical settings, it delivers accurate assessments for diagnosing, screening, and monitoring asthma. The device features a rechargeable battery for portability, an easy-to-use interface, and effectively determines if patients require treatment or inhaler prescriptions.

Which Companies Hold Significant Positions In The Breath Biopsy Testing Market?

Major companies operating in the breath biopsy testing market are Drägerwerk AG & Co. KGaA, Intoximeters Inc., Owlstone Medical Ltd., SKC Inc, Lifeloc Technologies Inc., Alcolizer Pty Ltd., Breathomix, Aerocrine AB, Bedfont Scientific Ltd., AK GlobalTech Corp., Alveo Technologies Inc., Andatech Pty Ltd., BACtrack, Biosensia Ltd., Ionicon, Ketonix AB, Lion Laboratories Limited, Menssana Research Inc., Microplex Inc., Quest Products Inc., Rapid Biosensor Systems Ltd., RoboScientific Ltd., Spirosure

Read the full breath biopsy testing market report here:

https://www.thebusinessresearchcompany.com/report/breath-biopsy-testing-global-market-report

How Does The Breath Biopsy Testing Market Perform Across Major Global Regions?

North America was the largest region in the breath biopsy testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the breath biopsy testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Breath Biopsy Testing Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=19351&type=smp

Browse Through More Reports Similar to the Global Breath Biopsy Testing Market 2026, By The Business Research Company

Biopsy Devices Global Market Report

https://www.thebusinessresearchcompany.com/report/biopsy-devices-global-market-report

Liquid Biopsy For Cancer Diagnostics Global Market Report

https://www.thebusinessresearchcompany.com/report/liquid-biopsy-for-cancer-diagnostics-global-market-report

Smart Biopsy Devices Global Market Report

https://www.thebusinessresearchcompany.com/report/smart-biopsy-devices-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795